<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04244695</url>
  </required_header>
  <id_info>
    <org_study_id>OrthoTU11</org_study_id>
    <nct_id>NCT04244695</nct_id>
  </id_info>
  <brief_title>Oral Steroid in Controlling Pain After TKA</brief_title>
  <official_title>Efficacy of Oral Corticosteroid in Controlling Pain After Total Knee Arthroplasty: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thammasat University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thammasat University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare efficacy of oral steroid in controlling pain after TKA
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare pain and functional outcome for oral dexamethasone 16 mg, 8 mg and pacebo in
      patient undergoing unilateral primary total knee arthroplasy
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain level</measure>
    <time_frame>12, 24 ,36, 48, 60 and 72 hours after surgery</time_frame>
    <description>VAS for pain (0-100) at rest and on motion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>nausea and vomiting</measure>
    <time_frame>in the first 72 hours after surgery</time_frame>
    <description>rate of nausea and vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion of the knee</measure>
    <time_frame>24, 72 hours then 2, 6, 12 weeks after surgery</time_frame>
    <description>Flexion and extension angle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>2, 6,12 weeks after surgery</time_frame>
    <description>Modified WOMAC score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood sugar</measure>
    <time_frame>At 8.00 am of 1, 2, 3 days after surgery</time_frame>
    <description>Fasting blood sugar level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inflammatory level</measure>
    <time_frame>At 8.00 am of 1, 2, 3 days and 2 weeks after surgery</time_frame>
    <description>C-reactive protein level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound complications</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Deep and superficial wound infection, wound dehiscense</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain, Acute</condition>
  <arm_group>
    <arm_group_label>Dexamethasone 16 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexamethasone (4mg) 4 tab oral once daily in the morning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone 8 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone (4mg) 2 tab and placebo 2 tab oral once daily in the morning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo 4 tab oral once daily in the morning</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone Oral</intervention_name>
    <description>To compare oral dexamethasone 16 mg vs 8 mg vs placebo in pateints undergoing unilateral TKA</description>
    <arm_group_label>Dexamethasone 16 mg</arm_group_label>
    <arm_group_label>Dexamethasone 8 mg</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with osteoarthritis of the knee who undergoing unilateral TKA

          -  ASA class I-III

          -  Informed consent

          -  Good cognitive function

        Exclusion Criteria:

          -  Uncontrolled DM (HbA1C &gt; 7)

          -  Uncontrolled HT

          -  Morbid obesity (BMI &gt; 40)

          -  History of bleeding in GI tract

          -  Corticosteroid used within 6 months

          -  Sever liver or renal impairments

          -  Studied drug allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>department of orthopaedic surgery, Faculty of medicine, Thammasat university</name>
      <address>
        <city>Khlong Luang</city>
        <state>Pathumthani</state>
        <zip>066</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>supakit kanitnate</last_name>
      <phone>6629260000</phone>
      <email>naypeng@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Nattapol Tammachote, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Supakit Kanitnate, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 24, 2020</study_first_submitted>
  <study_first_submitted_qc>January 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>January 24, 2020</last_update_submitted>
  <last_update_submitted_qc>January 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Thammasat University</investigator_affiliation>
    <investigator_full_name>Supakit Kanitnate</investigator_full_name>
    <investigator_title>membership</investigator_title>
  </responsible_party>
  <keyword>oral corticosteroid</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

